Senestech (NASDAQ:SNES) Issues Quarterly Earnings Results, Misses Estimates By $0.05 EPS

Senestech (NASDAQ:SNES) released its quarterly earnings results on Tuesday. The company reported ($0.36) earnings per share for the quarter, missing the consensus estimate of ($0.31) by ($0.05), FiscalAI reports. Senestech had a negative return on equity of 71.89% and a negative net margin of 294.73%. The firm had revenue of $1.10 million for the quarter, compared to analysts’ expectations of $0.92 million.

Senestech Stock Performance

SNES stock traded down $0.11 during midday trading on Tuesday, hitting $1.03. The company’s stock had a trading volume of 41,207 shares, compared to its average volume of 364,688. The stock has a market cap of $5.58 million, a price-to-earnings ratio of -0.75 and a beta of 0.11. The company has a quick ratio of 5.81, a current ratio of 6.78 and a debt-to-equity ratio of 0.02. The stock’s 50-day moving average price is $0.85 and its 200 day moving average price is $1.46. Senestech has a 1 year low of $0.55 and a 1 year high of $3.40.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Senestech in a research report on Wednesday, November 4th. One analyst has rated the stock with a Sell rating. According to data from MarketBeat.com, the stock currently has a consensus rating of “Sell”.

Insider Activity

In related news, major shareholder Glenbrook Capital Management purchased 28,000 shares of the business’s stock in a transaction that occurred on Wednesday, October 28th. The shares were bought at an average cost of $0.97 per share, with a total value of $27,160.00. Following the acquisition, the insider owned 2,194,973 shares of the company’s stock, valued at $2,129,123.81. This represents a 1.29% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. Over the last ninety days, insiders acquired 1,123,679 shares of company stock worth $814,836. Company insiders own 2.20% of the company’s stock.

Senestech Company Profile

SenesTech, Inc. is a biotechnology company focused on developing fertility-control technologies for managing animal populations. The company’s approach is designed to reduce reproduction rather than rely solely on lethal control methods, with applications primarily in rodent management. SenesTech’s principal product is ContraPest, a liquid bait designed to reduce fertility in rats by affecting reproductive function in both male and female animals. The product is intended for use in commercial, municipal and other settings where rat populations pose sanitation, health or property risks.